SKI Market

A+| A| A-|

Indian Indices

Sensex

78,136.76 949.89
( 1.23%)

Global Indices

Nasdaq

52,569.33 -110.31
(-0.21%)

Dow Jones

7,555.54 -37.86
(-0.50%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,555.24 39.32
(0.37%)

Forex

USD-INR

96.26 0.11
(0.12%)

EUR-INR

110.12 0.41
(0.38%)

GBP-INR

129.49 0.88
(0.69%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

35.16

868.95

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.07

Back

ncc ltd

Welspun Living consolidated net profit declines 99.83% in the December 2025 quarter

Feb 12,2026

Net profit of Welspun Living declined 99.83% to Rs 0.21 crore in the quarter ended December 2025 as against Rs 120.83 crore during the previous quarter ended December 2024. Sales declined 9.13% to Rs 2262.20 crore in the quarter ended December 2025 as against Rs 2489.61 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2262.20	2489.61	-9
OPM %	7.09	11.26	-
PBDT	135.66	256.61	-47
PBT	33.43	158.38	-79
NP	0.21	120.83	-100

78,136.76 949.89 ( 1.23%)

52,569.33 -110.31 (-0.21%)

7,555.54 -37.86 (-0.50%)

63,887.74 -2,947.80 (-4.41%)

10,555.24 39.32 (0.37%)

96.26 0.11 (0.12%)

110.12 0.41 (0.38%)

129.49 0.88 (0.69%)

0.59 0.00 (0.14%)